| First Author | Achilly NP | Year | 2021 |
| Journal | Nature | Volume | 592 |
| Issue | 7855 | Pages | 596-600 |
| PubMed ID | 33762729 | Mgi Jnum | J:306869 |
| Mgi Id | MGI:6710182 | Doi | 10.1038/s41586-021-03369-7 |
| Citation | Achilly NP, et al. (2021) Presymptomatic training mitigates functional deficits in a mouse model of Rett syndrome. Nature 592(7855):596-600 |
| abstractText | Mutations in the X-linked gene MECP2 cause Rett syndrome, a progressive neurological disorder in which children develop normally for the first one or two years of life before experiencing profound motor and cognitive decline(1-3). At present there are no effective treatments for Rett syndrome, but we hypothesized that using the period of normal development to strengthen motor and memory skills might confer some benefit. Here we find, using a mouse model of Rett syndrome, that intensive training beginning in the presymptomatic period dramatically improves the performance of specific motor and memory tasks, and significantly delays the onset of symptoms. These benefits are not observed when the training begins after symptom onset. Markers of neuronal activity and chemogenetic manipulation reveal that task-specific neurons that are repeatedly activated during training develop more dendritic arbors and have better neurophysiological responses than those in untrained animals, thereby enhancing their functionality and delaying symptom onset. These results provide a rationale for genetic screening of newborns for Rett syndrome, as presymptomatic intervention might mitigate symptoms or delay their onset. Similar strategies should be studied for other childhood neurological disorders. |
